Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology ... San Antonio Breast Cancer Symposium ...
News
- Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune ... - Yahoo Finance
- Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune ...
... biotechnology company developing therapies that selectively reprogram ... San Antonio Breast Cancer Symposium(SABCS), taking place on Dec. 8 ...
- Setara Biosciences Launches in San Diego With $90M, Lead Drug - Hoodline
San Diego Biotech Setara Launches With $90M and a Rare Disease Drug Already in People ... SAN ANTONIO SAN DIEGO SAN FERNANDO VALLEY SEATTLE SOMA SOUTH ...
- Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune ... - TradingView
... biotechnology company developing therapies that selectively reprogram cancer biolo ... San Antonio Breast Cancer Symposium ("SABCS"), taking place on ...
- Key indicators point to a slightly weaker San Antonio economy heading into fall | TPR
Bioscience-Medicine · Border & Immigration · Economy ... The state allocated back to San Antonio more than $38 million for the month of September.